Deoxyribozyme for promoting tumor cell apoptosis
A technology of tumor cell apoptosis and deoxyribozyme, which is applied in anti-tumor drugs, gene therapy, DNA/RNA fragments, etc., can solve the problems of cell apoptosis and tumor cell overgrowth, and achieve the promotion of apoptosis and low synthesis cost Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0022] Example 1: Analysis and screening of targeted bcl-2 and bcl-xL mRNA deoxyribozyme cleavage sites
[0023] Bcl-2 and Bcl-xL are highly expressed in many tumors, and inhibiting the expression of Bcl-2 or Bcl-xL can promote tumor cell apoptosis.
[0024] In this example, the Bcl-2 cDNA clone used for DNAzyme design contains a 31bp 5'UTR, a 720bp ORF, and a 2.2kb 3'UTR sequence. By scanning bcl-2mRNA, 141 potential AU and GU cutting sites were identified. Take 9 nucleotides at the 5'end of these cutting sites (not including the R at the cutting site R*Y) and 9 nucleotides at the 3'end (including the Y at the cutting site R*Y) For the sequence, the thermodynamic stability analysis of the enzyme-substrate complex (-ΔG°kcal / mol) was performed on the sequence to obtain the hybridization free energy of the sequence at each site. Further analysis obtained the Tm value to ensure that the DNAzyme does not form an intramolecular structure. Through the above analysis, based on -25kcal / ...
Example Embodiment
[0030] Example 2: Inhibition of DNAzyme on the expression of bcl-2 in tumor cells
[0031] Bcl-2 and Bcl-xL are highly expressed in many tumors. In order to verify the activity of the deoxyribozymes selected in vitro in cells, we selected the deoxyribozymes targeting Bcl-2 with higher activity in vitro, and used the transfection reagent TMP to transfect different deoxyribozymes at a concentration of 2mM. Tumor cells. After 24 hours, the cell protein was extracted for Western Blot analysis. figure 2 The results showed that the deoxyribozymes DT895, DT899, DT908, DT910, and DT912 that target Bcl-2 can inhibit the expression of Bcl-2 in prostate cancer cell PC3 and bladder cancer cell T24.
Example Embodiment
[0032] Example 3: Inhibition of DNAzyme on the expression of bcl-xL in tumor cells
[0033] The same analysis of DNAzyme targeting Bcl-xL showed that ( image 3 ), DT888, DT884, DT883, DT882 show strong inhibitory effects in prostate cancer cell PC3. DT882 was further selected for analysis in the bladder cancer cell line T24, lung cancer cell line A549, and colon cancer cell line HCT116. The results showed that DT882 could effectively inhibit the expression of Bcl-xL in these cells.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap